DPCR1 Antikörper
-
- Target Alle DPCR1 Antikörper anzeigen
- DPCR1 (Diffuse Panbronchiolitis Critical Region 1 (DPCR1))
- Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser DPCR1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Kreuzreaktivität
- Human
- Aufreinigung
- Purified by Protein A.
- Immunogen
- KLH conjugated synthetic peptide derived from human DPCR1
- Isotyp
- IgG
- Top Product
- Discover our top product DPCR1 Primärantikörper
-
-
- Applikationshinweise
-
WB 1:300-5000
IHC-P 1:200-400
IF(IHC-P) 1:50-200 - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 μg/μL
- Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- Haltbarkeit
- 12 months
-
- Target
- DPCR1 (Diffuse Panbronchiolitis Critical Region 1 (DPCR1))
- Andere Bezeichnung
- DPCR1 (DPCR1 Produkte)
- Synonyme
- PBLT antikoerper, Gm630 antikoerper, diffuse panbronchiolitis critical region 1 antikoerper, diffuse panbronchiolitis critical region 1 (human) antikoerper, DPCR1 antikoerper, Dpcr1 antikoerper
- Hintergrund
-
Synonyms: Dfuse panbronchiolitis critical region 1, Dfuse panbronchiolitis critical region, Dfuse panbronchiolitis critical region protein 1, DKFZp666O235, DPCR protein, MGC126710, MGC126712, OTTHUMP00000062447, PBLT, bCX105N19.6, DPCR1_HUMAN.
Background: Making up nearly 6 % of the human genome, chromosome 6 contains around 1,200 genes within 170 million base pairs of sequence. Deletion of a portion of the q arm of chromosome 6 is associated with early onset intestinal cancer, suggesting the presence of a cancer susceptibility locus. Porphyria cutanea tarda is associated with chromosome 6 through the HFE gene which, when mutated, predisposes an individual to developing this porphyria. Notably, the PARK2 gene, which is associated with Parkinson's disease, and the genes encoding the major histocompatiblity complex proteins, which are key molecular components of the immune system and determine predisposition to rheumatic diseases, are also located on chromosome 6. Stickler syndrome, 21-hydroxylase deficiency and maple syrup urine disease are also associated with genes on chromosome 6. A bipolar disorder susceptibility locus has been identified on the q arm of chromosome 6.
- Gen-ID
- 135656
-